201920182017201620152014 August 09, 2018 Summary ToggleSpero Therapeutics Announces Second Quarter 2018 Financial Results and Pipeline Overview July 16, 2018 Summary ToggleSpero Awarded up to $54 Million by BARDA and DTRA to Support SPR994 Development July 12, 2018 Summary ToggleSpero Therapeutics Announces Pricing of Securities Offering July 09, 2018 Summary ToggleSpero Therapeutics Announces Proposed Offering of Common Stock July 09, 2018 Summary ToggleSpero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994 June 05, 2018 Summary ToggleSpero Therapeutics to Present New Preclinical Data for SPR994 at ASM Microbe 2018 June 01, 2018 Summary ToggleSpero Therapeutics to Present at the Jefferies 2018 Healthcare Conference in June May 23, 2018 Summary ToggleSpero Therapeutics Announces Positive Top-Line Data for Two Product Candidates from its Potentiator Platform May 10, 2018 Summary ToggleSpero Therapeutics Announces First Quarter 2018 Financial Results and Pipeline Update May 01, 2018 Summary ToggleSpero Therapeutics to Present at Bank of America Merrill Lynch Health Care Conference in May Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
